Who is sponsoring NCT04428320?

NCT04428320 is sponsored by The Cooper Health System.

What drugs are being tested in NCT04428320?

Interventions in NCT04428320: Pelvic floor injection.

What condition does NCT04428320 study?

NCT04428320 studies Pelvic Floor Prolapse, Surgery, Pain, Postoperative.

Is NCT04428320 still recruiting?

NCT04428320 is currently status unknown. Last updated 11 June 2020.

Last reviewed 2020-06-11 · How we verify

NCT04428320

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Preemptive Levator Ani Injections on Pain After Pelvic Reconstructive Surgery

Status unknown NA Last updated 11 June 2020

What this trial tests

NA trial testing Pelvic floor injection in Pelvic Floor Prolapse in 140 participants. Status unknown.

Timeline

21 May 2020

Primary endpoint
21 May 2022

21 May 2022

Quick facts

Lead sponsor	The Cooper Health System
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	140
Start date	21 May 2020
Primary completion	21 May 2022
Estimated completion	21 May 2022
Sites	1 location across United States

Drugs / interventions tested

Pelvic floor injection

Conditions studied

Pelvic Floor Prolapse — all drugs for Pelvic Floor Prolapse →
Surgery — all drugs for Surgery →
Pain, Postoperative — all drugs for Pain, Postoperative →

Sponsor

The Cooper Health System — full company profile →

Who can join

18 and older, female only, with Pelvic Floor Prolapse or Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients undergoing vaginal pelvic reconstructive surgery for pelvic organ prolapse (POP) under general anesthesia will be randomized to receive bilateral trans-vaginal pelvic floor muscle injections with bupivacaine or no injection (standard of care) as a part of their surgical pain control

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pelvic Floor Prolapse

Currently open trials in the same condition.

NCT04547816 — Efficacy of Conservative Treatment of Functional Defecatory Disorders in Females With Pelvic Organ Prolapse · Phase 3 · recruiting

Other The Cooper Health System trials

Trials by the same sponsor.

NCT07296120 — RSV Vaccine Response in Stem Cell and CAR-T Therapy Recipients · Phase 4 · not yet recruiting
NCT07042048 — Placing External Ventricular Drains Using Assistive Augmented Reality or Image-Based Localization · NA · not yet recruiting
NCT06462781 — Localized Injection of Lidocaine and Glucocorticoid for Headache Treatment Phase 1 · Phase 1 · completed
NCT05974423 — Randomized Trial of Narcotic vs Non-Narcotic Pain Modulation After Labrum Repair · Phase 4 · unknown
NCT06398366 — Cardiac Abnormalities in Stroke Prevention and Risk of Recurrence · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04428320 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The Cooper Health System
Last refreshed: 11 June 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04428320.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing